Receptors in the amygdala suggest potential interactions between GLP-1 signaling and anxiety or stress processing
Some patients with conditions like rheumatoid arthritis or lupus have experienced improvements in disease activity markers alongside semaglutide use, possibly due to reduced metabolic inflammation
Yes, compounded semaglutide may have inconsistent quality, unknown ingredients, and a lack of accountability, which can lead to adverse effects or ineffective treatment
The researchers initially hypothesized that people carrying the PAM variant would have lower GLP-1 levels, based on the assumption that the hormone might be less stable when amidation is impaired
All-round guidance
K., Kuusela, M., Heikkinen, A., Muniandy, M., Kolk, B